ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0547

EspANDE Project: Improvement of Primary Care-Rheumatology Coordination in Spondyloarthritis in a Health Area in Northern Spain

Julio Sánchez-Martín1, Cristina Martinez-Dubois2, Javier Rueda Gotor3, Gabriel Pinedo-Lopez2, Alvaro Perez-Martin2, Roberto Gonzalez-Santamaria2, Belén Atienza-Mateo4, Vanesa Calvo-Rio5, Inigo Gonzalez-Mazon6, Natalia Palmou Fontana4, Enriqueta Peiro-Callizo2, Diana Prieto-Peña4, Lara Sanchez Bilbao7, Fernando Lopez-Gutierrez8 and Ricardo Blanco-Alonso9, 1Hospital Universitario 12 de Octubre, Madrid, Spain, 2Department of Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Immunopathology Group, Santander, Spain, Santander, Cantabria, Spain, 3Hospital Sierrallana, Torrelavega, Cantabria, Spain, 4Division of Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Immunopathology group, Santander, Cantabria, Spain, 5Valdecilla Hospital, Santander, Cantabria, Spain, 6H. U. Marques de Valdecilla, Santander, Cantabria, Spain, 7Rheumatology and Ophthalmology. Hospital Universitario Marques de Valdecilla, Santander, Cantabria, Spain, 8Rheumatology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Cantabria, Spain, 9Division of Rheumatology, Hospital Universitario Marqués de Valdecilla. IDIVAL, Immunopathology group, Santander, Spain

Meeting: ACR Convergence 2024

Keywords: primary care, quality of care, spondyloarthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: SpA Including PsA – Diagnosis, Manifestations, & Outcomes Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: Spondyloarthritis (SpA) constitutes a diverse set of inflammatory rheumatic diseases with a prevalence of 1.9% in the general population. Diagnostic delay, identified as a determining factor in the worsening of the disease, has been pointed out in the ATLAS 2017 study with an average of almost 9 years, significantly affecting the quality of life of patients1,2,3. This study addresses early detection as a crucial challenge for health professionals, seeking to improve the functional situation of patients, reduce comorbidities and prevent loss of quality of life.

The EspAnde project focuses on optimizing the coordination between Primary Care (PC) and Rheumatology, through the Musculoskeletal Unit (MSU), with the purpose of identifying, implementing and evaluating improvements in the care pathway for patients with spondyloarthritis. The objective is to promote early referral, reducing diagnosis and treatment times.

Methods: A Working Group composed of PC physicians and rheumatologists from the MSU was founded. The current situation of the care process for patients with spondyloarthritis in the Health Area was analyzed, developing solutions such as an early referral algorithm and a screening test (PURE 4), both integrated into the PC Cantabria computer program. The MSU provided training to PC professionals for correct implementation. Impact monitoring and measurement was carried out, including analysis of results.

Results: In 2021, the diagnostic delay in patients with SpA in the Santander area was 44 months. Two years after the implementation of the project, a significant reduction was achieved, reaching an average diagnosis time of 16 months in 2023, representing a median decrease of 28 months (Figure 1). In 2023, upon arrival at the Rheumatology department, 71% of patients were able to confirm or rule out the diagnosis on the first visit, compared to 43% at baseline, indicating a positive impact of the project on the efficiency of early diagnosis.

Conclusion: The EspAnde project has proven to be highly effective by significantly reducing the diagnostic delay of spondyloarthritis in the Santander area, going from 44 months in 2021 to 16 months in 2023. The collaboration between Primary Care and Rheumatology, supported by algorithms and screening tests, has improved diagnostic certainty upon reaching the Rheumatology service, reaching 71% in 2023. This approach has also strengthened care coordination and highlights the importance of the sustainability and continuity of these practices. Furthermore, early detection is expected to have a positive impact on patients’ quality of life. These lessons learned and encouraging results suggest potential for replication and adaptation of these strategies in other healthcare settings.

Supporting image 1


Disclosures: J. Sánchez-Martín: None; C. Martinez-Dubois: None; J. Rueda Gotor: None; G. Pinedo-Lopez: None; A. Perez-Martin: None; R. Gonzalez-Santamaria: None; B. Atienza-Mateo: None; V. Calvo-Rio: AstraZeneca, 6, GlaxoSmithKlein(GSK), 6, Janssen, 6, otsuka, 6; I. Gonzalez-Mazon: None; N. Palmou Fontana: None; E. Peiro-Callizo: None; D. Prieto-Peña: None; L. Sanchez Bilbao: None; F. Lopez-Gutierrez: AstraZeneca, 12, Formation/Congress attendance, 12, Formation/Congress attendance, Novartis, 12, Formation/congress attendance; R. Blanco-Alonso: AbbVie, 2, 5, 6, Bristol-Myers Squibb, 2, 6, Galapagos, 6, Janssen, 2, 6, Lilly, 2, 6, MSD, 2, 5, 6, Pfizer, 2, 6, Roche, 2, 5, 6.

To cite this abstract in AMA style:

Sánchez-Martín J, Martinez-Dubois C, Rueda Gotor J, Pinedo-Lopez G, Perez-Martin A, Gonzalez-Santamaria R, Atienza-Mateo B, Calvo-Rio V, Gonzalez-Mazon I, Palmou Fontana N, Peiro-Callizo E, Prieto-Peña D, Sanchez Bilbao L, Lopez-Gutierrez F, Blanco-Alonso R. EspANDE Project: Improvement of Primary Care-Rheumatology Coordination in Spondyloarthritis in a Health Area in Northern Spain [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/espande-project-improvement-of-primary-care-rheumatology-coordination-in-spondyloarthritis-in-a-health-area-in-northern-spain/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/espande-project-improvement-of-primary-care-rheumatology-coordination-in-spondyloarthritis-in-a-health-area-in-northern-spain/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology